Document ID: chunk:federal_register_of_legislation:F2024L01730:schedule:1:p10
Version: federal_register_of_legislation:F2024L01730
Segment Type: schedule
Provision Reference: sch 1 (pt 10/30)
Character Range: 30165–32886

28  5     28
Fluoxetine  Capsule 20 mg (as hydrochloride)  Oral  Prozac 20          LY  MP NP  C15582 C15666  P15582 P15666  56  2     28

[55] Schedule 1, Part 1, entries for Hypromellose in the form Eye drops 3 mg per mL, 10 mL
omit:
Hypromellose  Eye drops 3 mg per mL, 10 mL  Application to the eye  Genteal                 AQ  MP NP AO  C15560  P15560  1  5     1
Hypromellose  Eye drops 3 mg per mL, 10 mL  Application to the eye  Genteal                 AQ  MP NP AO  C15556  P15556  2  5     1
Hypromellose  Eye drops 3 mg per mL, 10 mL  Application to the eye  In a Wink Moisturising  IQ  MP NP AO  C15560  P15560  1  5     1
Hypromellose  Eye drops 3 mg per mL, 10 mL  Application to the eye  In a Wink Moisturising  IQ  MP NP AO  C15556  P15556  2  5     1

[56] Schedule 1, Part 1, omit entries for Hypromellose with carbomer 980
[57] Schedule 1, Part 1, entry for Imatinib in the form Capsule 100 mg (as mesilate) [Brand: ARX-IMATINIB; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[58] Schedule 1, Part 1, entry for Imatinib in the form Capsule 100 mg (as mesilate) [Brand: Imatinib-APOTEX; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[59] Schedule 1, Part 1, entry for Imatinib in the form Capsule 100 mg (as mesilate) [Brand: IMATINIB-DRLA; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[60] Schedule 1, Part 1, entry for Imatinib in the form Capsule 400 mg (as mesilate) [Brand: ARX-IMATINIB; Maximum Quantity: 30; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[61] Schedule 1, Part 1, entry for Imatinib in the form Capsule 400 mg (as mesilate) [Brand: Imatinib GH; Maximum Quantity: 30; Number of Repeats: 2]
(a) omit from the